In this regard, a recent report of a multicenter phase 1/2a trial for patients with cirrhosis found that low doses of PRI-724 significantly improved liver stiffness and reduced serum albumin levels, but not fibrosis [27]. This evidence concerns the gene ALB and Cirrhosis.